More tools:Markets·Screener·Research·Chat

Bausch Health Companies Inc (BHC) Financial Statements

Bausch Health Companies Inc
SIC 2834 · PHARMACEUTICAL PREPARATIONS
FIGI BBG001S7WDP0
XNYS · usd
6.69▲ 0.26 (3.97%)
As of 2026-09-09
Valuation
Market Cap
Enterprise Value
Trailing P/E—
Price / Sales
EV / Revenue
EV / EBITDA
Financial Highlights
Revenue (TTM)
Net Income (TTM)
EBITDA
Diluted EPS (TTM)
EBITDA Margin
Net Debt
Trading Information
Previous Close6.43
Day's Range6.41 – 6.69
52-Week Range4.33 – 8.00
Volume1.8M
Avg Volume4.3M
Share Statistics
Shares Outstanding
Employees20.3K
ExchangeXNYS
Listed1994-03-31
Share count as of July 24, 2026
Loading Income Statement…
Key questions about Bausch Health Companies Inc (BHC)
What is Bausch Health Companies Inc's Market Cap?
Bausch Health Companies Inc's Market Cap is $2.5B, based on as-reported figures from SEC (XBRL) filings.
What is Bausch Health Companies Inc's Enterprise Value?
Bausch Health Companies Inc's Enterprise Value is $21.4B, based on as-reported figures from SEC (XBRL) filings.
What is Bausch Health Companies Inc's Price / Sales?
Bausch Health Companies Inc's Price / Sales is 0.2×, based on as-reported figures from SEC (XBRL) filings.
What is Bausch Health Companies Inc's EV / Revenue?
Bausch Health Companies Inc's EV / Revenue is 2.0×, based on as-reported figures from SEC (XBRL) filings.
What is Bausch Health Companies Inc's EV / EBITDA?
Bausch Health Companies Inc's EV / EBITDA is 10.4×, based on as-reported figures from SEC (XBRL) filings.
What is Bausch Health Companies Inc's Revenue (TTM)?
Bausch Health Companies Inc's Revenue (TTM) is $10.9B, based on as-reported figures from SEC (XBRL) filings.
What is Bausch Health Companies Inc's Net Income (TTM)?
Bausch Health Companies Inc's Net Income (TTM) is -$1.1B, based on as-reported figures from SEC (XBRL) filings.
What is Bausch Health Companies Inc's EBITDA?
Bausch Health Companies Inc's EBITDA is $2.1B, based on as-reported figures from SEC (XBRL) filings.
What is Bausch Health Companies Inc's Diluted EPS (TTM)?
Bausch Health Companies Inc's Diluted EPS (TTM) is -2.94, based on as-reported figures from SEC (XBRL) filings.
What is Bausch Health Companies Inc's EBITDA Margin?
Bausch Health Companies Inc's EBITDA Margin is 18.9%, based on as-reported figures from SEC (XBRL) filings.
Showing the most recent year. Subscribe for full statement history.
Income Statement(in millions of USD, except per-share data)
Source: Akyla.ai
Line ItemJun 30, 2026Mar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022
Revenues
Revenues
YoY growth+12.7%+11.7%+9.3%+6.8%
Expenses
Selling, general and administrative
Research and development
Amortization of intangible assets
Goodwill impairments——
Restructuring, integration and separation costs
Other expense (income), net
Total expenses
% of revenue74.1%137.6%83.0%76.9%
Operating income (loss)
% of revenue25.9%-37.6%17.0%23.1%
Interest income
Interest expense
Gain (loss) on extinguishment of debt
Foreign exchange and other
Income (loss) before income taxes
Provision for income taxes
Net income (loss)
% of revenue9.1%-56.7%-3.7%6.8%
Net (income) loss attributable to noncontrolling interest
Net income (loss) attributable to Bausch Health Companies Inc.
% of revenue9.0%-56.4%-4.0%6.7%
Earnings (loss) per share attributable to Bausch Health Companies Inc.
Basic loss per share attributable to Bausch Health Companies Inc. (in usd per share)
Diluted loss per share attributable to Bausch Health Companies Inc. (in usd per share)